Skip to main content
. 2021 May 6;80(8):1022–1030. doi: 10.1136/annrheumdis-2020-219717

Figure 3.

Figure 3

Time-to-flare. P value vs withdrawn to placebo: †p<0.01, ‡p<0.001. IXE, ixekizumab; Q2W, every 2 weeks; Q4W, every 4 weeks.